Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMyhlth Chck Regulatory News (MHC)

Share Price Information for Myhlth Chck (MHC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 10.00
Bid: 9.50
Ask: 10.50
Change: 0.00 (0.00%)
Spread: 1.00 (10.526%)
Open: 10.00
High: 10.00
Low: 10.00
Prev. Close: 10.00
MHC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Health Inspectorate Wales registration

3 May 2023 07:00

RNS Number : 1907Y
MyHealthChecked PLC
03 May 2023
 

 

MyHealthChecked PLC

("MyHealthChecked" or the "Company")

 

Health Inspectorate Wales registration

Registration for MyHealthChecked's tests demonstrate compliance with national standards

 

MyHealthChecked PLC (AIM: MHC), the consumer home-testing healthcare company, announces that it has received a Notice of Decision confirming that MyHealthChecked is now registered with the Healthcare Inspectorate Wales ('HIW'). To achieve this status, MyHealthChecked has gone through a rigorous process to ensure that all of the Company's processes are compliant with national regulatory standards in Wales in relation to oversight of test results, and the provision of phlebotomy services.

 

Healthcare Inspectorate Wales (https://www.hiw.org.uk/) is the independent inspector and regulator of all healthcare in Wales (NHS and independent healthcare providers). Being registered with HIW provides MyHealthChecked's customers with assurance that the Company is performing to the highest standards of compliance, as agreed by an organisation that is independent, fair and evidence driven, and committed to taking action to improve poor standards, whilst also recognising good practice. It also provides confidence to MyHealthChecked customers that the Company is independently regulated and will provide safe, timely and good quality care and the needs of customers are prioritised.

 

Registration with HIW is essential for MyHealthChecked to provide doctor oversight for MyHealthChecked blood and blood/urine tests, as well as enabling it to offer phlebotomy services through B2B retail partners. The Registration covers all the tests in MyHealthChecked's new product portfolio.

 

Penny McCormick, Chief Executive Officer of MyHealthChecked PLC, said: "Receiving this accreditation from Healthcare Inspectorate Wales provides MyHealthChecked and our partners with the assurance that we are deemed to be operating to the highest standards. This registration from an independent body also further validates the quality of our at-home wellness testing service and our commitment to patient care. This is an essential precursor to any nationwide launch of the products into a retail partner."

 

For further information contact:

 

MyHealthChecked PLC

www.myhealthchecked.com

Penny McCormick, Chief Executive Officer

via Walbrook PR

SPARK Advisory Partners Limited (NOMAD)

Tel: +44 (0)20 3368 3550

Neil Baldwin

Dowgate Capital Limited (Broker)

Tel: +44 (0)20 3903 7715

David Poutney / Nicholas Chambers

Walbrook PR Ltd (Media & IR)

Tel: +44 (0)20 7933 8780 or myhealthcheckedplc@walbrookpr.com

Paul McManus / Alice Woodings

Mob: +44 (0)7980 541 893 / +44 (0)7407 804 654

 

About MyHealthChecked PLC (https://investors.myhealthchecked.com/)

 

MyHealthChecked PLC, based in Cardiff, is an AIM-quoted pioneering UK healthcare company focused on a range of at-home healthcare and wellness tests.

 

MyHealthChecked is the umbrella brand of a range of at-home rapid tests, as well as DNA, RNA and blood sample collection kits which have been created to support customers on their journeys to wellness. The tests are lateral-flow self-tests, whilst the sample collection kits enable the collection of blood, urine, nasal or mouth swab samples that are analysed in partner laboratories for a range of biomarkers. The tests will also be made available online and will be viable for over-the-counter purchase. 

 

The MyHealthChecked portfolio has been identified as part of a change in mindset as customers become more familiar with the concept of accessible healthcare in the growing at home testing kit market with a focus on accessibility at the right price, led by UK-based experts.

 

About Reach announcements

 

Reach is an investor communication service aimed at assisting listed and unlisted (including AIM quoted) companies to distribute media only / non-regulatory news releases such as marketing messages, corporate and product information into the public domain. An RNS Regulatory announcement is required to be notified under the AIM Rules for Companies.

 

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRADZGGKGZFGFZZ
Date   Source Headline
25th Mar 20227:00 amRNSIssue of Equity
16th Mar 20222:05 pmRNSSecond Price Monitoring Extn
16th Mar 20222:00 pmRNSPrice Monitoring Extension
7th Mar 20222:06 pmRNSSecond Price Monitoring Extn
7th Mar 20222:00 pmRNSPrice Monitoring Extension
3rd Mar 20221:05 pmRNSDirectorate Change
28th Feb 202211:05 amRNSSecond Price Monitoring Extn
28th Feb 202211:00 amRNSPrice Monitoring Extension
2nd Feb 20224:41 pmRNSSecond Price Monitoring Extn
2nd Feb 20224:36 pmRNSPrice Monitoring Extension
24th Jan 20227:00 amRNSTrading Update
5th Jan 20227:00 amRNSPartnership with Lloyds for COVID Antigen testing
13th Dec 20214:40 pmRNSSecond Price Monitoring Extn
13th Dec 20214:35 pmRNSPrice Monitoring Extension
13th Dec 20217:00 amRNSTrading update
7th Dec 20214:41 pmRNSSecond Price Monitoring Extn
7th Dec 20214:36 pmRNSPrice Monitoring Extension
1st Dec 20214:41 pmRNSSecond Price Monitoring Extn
1st Dec 20214:36 pmRNSPrice Monitoring Extension
1st Dec 202111:06 amRNSSecond Price Monitoring Extn
1st Dec 202111:00 amRNSPrice Monitoring Extension
29th Nov 202111:06 amRNSSecond Price Monitoring Extn
29th Nov 202111:01 amRNSPrice Monitoring Extension
26th Nov 202111:05 amRNSSecond Price Monitoring Extn
26th Nov 202111:00 amRNSPrice Monitoring Extension
25th Nov 202111:06 amRNSSecond Price Monitoring Extn
25th Nov 202111:00 amRNSPrice Monitoring Extension
24th Nov 20219:05 amRNSSecond Price Monitoring Extn
24th Nov 20219:00 amRNSPrice Monitoring Extension
24th Nov 20217:00 amRNSLaunch of COVID-19 rapid antigen test service
8th Oct 20214:41 pmRNSSecond Price Monitoring Extn
8th Oct 20214:36 pmRNSPrice Monitoring Extension
1st Oct 20217:00 amRNSBoard Change
29th Sep 20219:05 amRNSSecond Price Monitoring Extn
29th Sep 20219:00 amRNSPrice Monitoring Extension
29th Sep 20217:00 amRNSHalf-year Report
20th Sep 20212:01 pmRNSPrice Monitoring Extension
20th Sep 20217:00 amRNSStatement re. COVID-19 testing
17th Sep 20215:50 pmRNSStatement re. COVID-19 testing
13th Sep 20219:07 amRNSSecond Price Monitoring Extn
13th Sep 20219:03 amRNSPrice Monitoring Extension
7th Sep 20217:00 amRNSNotice of Results & Q3 Trading Update
1st Sep 20217:00 amRNSMedical laboratory accreditation for COVID testing
26th Aug 202111:05 amRNSSecond Price Monitoring Extn
26th Aug 202111:01 amRNSPrice Monitoring Extension
24th Aug 20217:00 amRNSStatement re. DHSC press release
30th Jul 20217:00 amRNSIssue of equity/PDMR Dealing
7th Jul 202111:06 amRNSSecond Price Monitoring Extn
7th Jul 202111:00 amRNSPrice Monitoring Extension
7th Jul 20219:06 amRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.